Sue-jean Lin - Net Worth and Insider Trading

Sue-jean Lin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sue-jean Lin owns 1 companies in total, including Arcutis Biotherapeutics Inc (ARQT) .

Click here to see the complete history of Sue-jean Lin’s form 4 insider trades.

Insider Ownership Summary of Sue-jean Lin

Ticker	Comapny	Transaction Date	Type of Owner
ARQT	Arcutis Biotherapeutics Inc	2021-06-09	director

Sue-jean Lin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sue-jean Lin Ownership Network

Ownership Network List of Sue-jean Lin

No Data

Ownership Network Relation of Sue-jean Lin

Sue-jean Lin Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Sue-jean Lin is the director of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & President and CEO Todd Franklin Watanabe , See Remarks Patrick Burnett , and SVP and General Counsel Masaru Matsuda .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Sue-jean Lin made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 119,269 shares made by Patrick Burnett , a net sale of 24,466 shares made by Masaru Matsuda , and a net sale of 60,000 shares made by Howard G. Welgus .

In summary, during the past 3 months, insiders sold 81,406 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 81,406 shares. During the past 18 months, 294,384 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 191,869 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Sue-jean Lin Mailing Address

Above is the net worth, insider trading, and ownership report for Sue-jean Lin. You might contact Sue-jean Lin via mailing address: C/o Arcutis Biotherapeutics, Inc., 3027 Townsgate Road, Suite 300, Westlake Village Ca 91361.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.